Aurobindo Pharma Limited — JV/Acquisition, 28-02-2025: Acquisition

Aurobindo Pharma has completed the acquisition of an 80% stake in Tergene Biotech Limited for a purchase consideration of ₹107.6 million. This acquisition transforms Tergene into a direct subsidiary, enhancing Aurobindo's strategic positioning in the biotech sector. The move is expected to facilitate operational synergies and expand market reach, potentially leading to increased shareholder value.